Company Filing History:
Years Active: 2008-2011
Title: Masayuki Shiseki: Innovator in Tumor Suppressor Research
Introduction
Masayuki Shiseki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, particularly in the area of tumor suppressor genes. With a total of 2 patents, his work has the potential to impact the diagnosis and treatment of various neoplastic conditions.
Latest Patents
Shiseki's latest patents focus on a novel tumor suppressor gene known as p28ING5. This disclosure provides nucleic acid molecules that encode the p28ING5 protein, along with methods for making and utilizing these molecules. The patents also outline methods for ameliorating, treating, detecting, prognosing, and diagnosing diseases associated with abnormal p28ING5 expression, such as neoplasia. Additionally, kits for these applications are included in the patent disclosures.
Career Highlights
Masayuki Shiseki is affiliated with the National Institutes of Health, a component of the U.S. Department of Health & Human Services. His work at this esteemed institution has allowed him to collaborate with leading experts in the field, further enhancing the impact of his research.
Collaborations
Some of Shiseki's notable coworkers include Curtis C. Harris and Remy Pedeux. Their collaborative efforts contribute to advancing the understanding of tumor suppressor genes and their applications in medical science.
Conclusion
Masayuki Shiseki's innovative work in tumor suppressor research exemplifies the critical role of inventors in advancing medical science. His contributions have the potential to lead to significant breakthroughs in the diagnosis and treatment of cancer.